ArticleInternational journal of general medicine2023

KIF20A is a Prognostic Marker for Female Patients with Estrogen Receptor-Positive Breast Cancer and Receiving Tamoxifen as Adjuvant Endocrine Therapy.

Xuchen Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.